secwatch.observer — SEC 8-K summary
======================================

Issuer:     CERO THERAPEUTICS HOLDINGS, INC. (CERO)
CIK:        0001870404
Form:       8-K
Filed at:   2025-04-22T23:59:59+00:00
Accession:  0001213900-25-033946
Event type: other_material
Sentiment:  neutral
Materiality: 0.80
Item codes: 1.01, 3.02, 8.01, 9.01
LLM model:  deepseek-v4-flash:cloud@v2

CERo raises up to $8M in Series D convertible; believes meets Nasdaq equity requirement
--------------------------------------------------------------------------------

- Closed initial $5M of up to $8M Series D convertible preferred; conversion price $0.78, floor $0.156.
- Believes meets $2.5M stockholders' equity after placement, prior $2.3M equity line & $4.1M Feb offering; delisting risk remains.
- Series D ranks senior to Series A & B, pari passu with Series C; 25% redemption premium on bankruptcy or company optional redemption.
- Proceeds to fund IND allowances, MDACC site activation, and extend cash runway, per press release.

Source:
  EDGAR index:    https://www.sec.gov/Archives/edgar/data/1870404/000121390025033946/0001213900-25-033946-index.htm
  Primary doc:    https://www.sec.gov/Archives/edgar/data/1870404/000121390025033946/ea0238925-8k_cerotherap.htm
  HTML page:      https://secwatch.observer/filing/0001213900-25-033946

License: Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer